BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24156100)

  • 1. Response to Effectiveness of adrenalectomy and aldosterone antagonists for long-term treatment of primary aldosteronism.
    Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
    Hypertension; 2013 Oct; 62(4):e14. PubMed ID: 24156100
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of adrenalectomy and aldosterone antagonists for long-term treatment of primary aldosteronism.
    Kaplan N
    Hypertension; 2013 Oct; 62(4):e13. PubMed ID: 23918755
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
    Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
    Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will the lessons from primary aldosteronism change the treatment of hypertension and left ventricular hypertrophy?
    Auchus RJ; Drazner MH
    Hypertension; 2007 Nov; 50(5):837-9. PubMed ID: 17909118
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies.
    Marzano L; Colussi G; Sechi LA; Catena C
    Am J Hypertens; 2015 Mar; 28(3):312-8. PubMed ID: 25336498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Taste Perception for Sodium Chloride in Patients With Primary Aldosteronism: A Prospective Cohort Study.
    Adolf C; Görge V; Heinrich DA; Hoster E; Schneider H; Handgriff L; Künzel H; Sturm L; Beuschlein F; Reincke M
    Hypertension; 2021 Apr; 77(4):1332-1340. PubMed ID: 33641355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.
    Morimoto S; Ichihara A
    Hypertens Res; 2020 Aug; 43(8):744-753. PubMed ID: 32424201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary hyperaldosteronism.
    Araujo-Castro M
    Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.
    Stavropoulos K; Papadopoulos C; Koutsampasopoulos K; Lales G; Mitas C; Doumas M
    Curr Pharm Des; 2018; 24(46):5508-5516. PubMed ID: 30854950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperaldosteronism: diagnosis, lateralization, and treatment.
    Harvey AM
    Surg Clin North Am; 2014 Jun; 94(3):643-56. PubMed ID: 24857581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.
    Lin YH; Lee HH; Liu KL; Lee JK; Shih SR; Chueh SC; Lin WC; Lin LC; Lin LY; Chung SD; Wu VC; Kuo CC; Ho YL; Chen MF; Wu KD;
    Surgery; 2011 Sep; 150(3):526-33. PubMed ID: 21514614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary aldosteronism and low-renin hypertension: a continuum?
    Funder JW
    Nephrol Dial Transplant; 2013 Jul; 28(7):1625-7. PubMed ID: 23535225
    [No Abstract]   [Full Text] [Related]  

  • 15. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
    Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
    J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
    Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
    JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism.
    Lechner B; Lechner K; Heinrich D; Adolf C; Holler F; Schneider H; Beuschlein F; Reincke M
    Eur J Endocrinol; 2019 Oct; 181(4):R147-R153. PubMed ID: 31299637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary aldosteronism and pregnancy.
    Morton A
    Pregnancy Hypertens; 2015 Oct; 5(4):259-62. PubMed ID: 26597737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
    Williams TA; Reincke M
    Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.
    Hundemer GL
    Curr Cardiol Rep; 2019 Jul; 21(9):93. PubMed ID: 31352525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.